Guardant Health, Inc.

Guardant Health, Inc.

GHยทNASDAQ

$127.03

-2.4%
HealthcareMedical - Diagnostics & Research

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.

At a Glance

Live Snapshot
Market Cap$16.84B
EPS-3.3200
P/E Ratio-30.76
Earnings Date07/29/2026

No Dividend Yield Data

GH has not reported any dividend yield values in the available annual periods.

No Dividend Payout Ratio Data

GH has not reported any dividend payout ratio values in the available annual periods.

No Net Dividends Paid Data

GH has not reported any net dividends paid values in the available annual periods.

Guardant Health, Inc.

Guardant Health, Inc. Dividend History

GH ยท NASDAQ
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%

GH Dividend Payment History

GH ยท NASDAQ
DeclarationEx-DatePayment DateDividendAdjustedFrequencyGrowth
No dividend payment history available
gh

Guardant Health, Inc. Payout Ratio Analysis

GH ยท NASDAQ
Dividends Paid
0.00
2025
Net Income
-416.28M
2025
Payout Ratio
0.00%
2025

Dividend Sustainability Analysis

Payout Ratio
0.00%

Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.

FCF Payout Ratio
0.0%

Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.

Sustainability
At Risk

Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.